Speciality: Hematology
Description:
A warm welcome to all the medical professionals in this memorable scientific session of thromboprophylaxis in medical settings. We have Dr. Ashish Bhalla, Dr. Tobias Tritschler and Dr. Bharat Jagiasi to lead this session.
The primary subject of discussion in this webinar is the increasing risk of hospital acquired deep vein thrombosis and pulmonary embolism among the patients. Get a broader knowledge of the above mentioned topics by learning about different instances.
Venous thromboembolism is the most common cause of death observed in surgical patients. Thromboprophylaxis is the mechanical method to promote venous outflow from the legs and antithrombotic drugs. This can be an effective means of reducing morbidity and mortality in the patients with hospital acquired deep vein thrombosis.
Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
2.
These Athletes Weren't Doping. Their Genes Made It Look Like They Did.
3.
Understudied mental health challenges among caregivers of cancer patients: A call for targeted support
4.
Women are more susceptible to the stress caused by inflation.
5.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
1.
Mastering Breast Cancer Care in 2025: Diagnosis, Treatment, Education, and Innovation
2.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
3.
The Mystery of Carotid Body Tumors: The Facts You Need to Know
4.
Real-World Evidence and Patient Voices: Redefining Outcomes in Modern Oncology
5.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
5.
Understanding the causes of anemia in adults beyond nutritional deficiencies
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation